S&P 500
(-0.04%) 5 431.60 points
Dow Jones
(-0.15%) 38 589 points
Nasdaq
(0.12%) 17 689 points
Oil
(-0.17%) $78.49
Gas
(-2.47%) $2.89
Gold
(1.31%) $2 348.40
Silver
(1.91%) $29.62
Platinum
(0.90%) $963.20
USD/EUR
(0.31%) $0.934
USD/NOK
(0.26%) $10.67
USD/GBP
(0.59%) $0.788
USD/RUB
(1.77%) $89.43

Realtime updates for Integrated BioPharma, [INBP]

Exchange: PNK Industry: Packaged Foods
Last Updated10 Jun 2024 @ 09:30

0.00% $ 0.240

Live Chart Being Loaded With Signals

Commentary (10 Jun 2024 @ 09:30):
Our systems believe the stock currently is overvalued by -28.99% compare to its pairs and should correct downwards.

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada...

Stats
Today's Volume 1 041
Average Volume 1 361
Market Cap 7.22M
EPS $0.00950 ( Q3 | 2024-05-10 )
Next earnings date ( $0 ) 2024-09-13
Last Dividend $0.500 ( 2008-08-19 )
Next Dividend $0 ( N/A )
P/E -24.00
(Sector) 0
(Industry) 0
ATR14 $0 (0.00%)
BABB 0.00%
BDPT 0.00%
BFNH 14.00%
BSFC 2.94%
BTTR 7.34%
CHHE 0.00%
FTLF -2.96%
GHAV 0.00%
INBP 0.00%
NCRA -7.48%
NGTF 0.00%
TLCC 0.00%
TOFB 1.27%
UPDC 9 900.00%
Insider Trading
Date Person Action Amount type
2023-11-28 Riva Sheppard Buy 150 000 Stock Option (right to buy)
2023-11-28 Kay Christina Buy 150 000 Stock Option (right to buy)
2023-11-28 Masi Dina Buy 150 000 Stock Option (right to buy)
2023-03-20 Kay E Gerald Sell 150 000 Stock Option (right to buy)
2023-03-20 Kay E Gerald Sell 100 000 Stock Option (right to buy)
INSIDER POWER
84.44
Last 98 transactions
Buy: 38 374 999 | Sell: 953 334
Correlation (AI algo v.1.1b): Overvalued: 28.99% $0.288 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Integrated BioPharma, Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Integrated BioPharma, Financials

Annual 2023
Revenue: $50.67M
Gross Profit: $4.06M (8.01 %)
EPS: $-0.00110
FY 2023
Revenue: $50.67M
Gross Profit: $4.06M (8.01 %)
EPS: $-0.00110
FY 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $0
FY 2022
Revenue: $56.25M
Gross Profit: $6.55M (11.65 %)
EPS: $0.130

Financial Reports:

No articles found.

Integrated BioPharma, Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Integrated BioPharma, Dividend Information - No Dividend Player

Dividend Sustainability Score: 6.47 - average (82.52%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.500 2008-08-19
Last Dividend $0.500 2008-08-19
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.500 --
Avg. Dividend % Per Year 0.00% --
Score 0.97 --
Div. Sustainability Score 6.47
Div.Growth Potential Score 0
Div. Directional Score 3.20 --
Next Divdend (Est)
(2024-06-16)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.97
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date Amount Declaration Date Record Date Payment Date
19 Aug 2008 $0.500 30 Nov -0001 30 Nov -0001 30 Nov -0001

Top 10 dividend Companies for PNK

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
BEBE Ex Dividend Junior 2023-09-18 Quarterly 0 0.00%
WAYN Ex Dividend Knight 2023-07-18 Quarterly 0 0.00%
CPTP Ex Dividend Knight 2023-08-10 Quarterly 0 0.00%
ENBP Ex Dividend Knight 2023-08-14 Quarterly 0 0.00%
HRNNF Ex Dividend Knight 2023-09-12 Quarterly 0 0.00%
PPBN Ex Dividend Knight 2023-08-17 Quarterly 0 0.00%
SBYSF Ex Dividend Junior 2023-09-20 Semi-Annually 0 0.00%
UEPEP Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
CMTV Ex Dividend Knight 2023-10-12 Quarterly 0 0.00%
EFSI Ex Dividend Knight 2023-08-04 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.001851.500-0.0370-0.0555[0 - 0.5]
returnOnAssetsTTM-0.004311.200-0.144-0.172[0 - 0.3]
returnOnEquityTTM-0.006171.500-1.180-1.769[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.630.8001.8531.483[1 - 3]
quickRatioTTM0.9700.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2911.5009.5010.00[0.2 - 2]
debtRatioTTM0.0757-1.5008.74-10.00[0 - 0.6]
interestCoverageTTM-9.001.000-4.44-4.44[3 - 30]
operatingCashFlowPerShareTTM0.01522.009.9910.00[0 - 30]
freeCashFlowPerShareTTM0.003102.0010.0010.00[0 - 20]
debtEquityRatioTTM0.108-1.5009.57-10.00[0 - 2.5]
grossProfitMarginTTM0.05721.000-2.38-2.38[0.2 - 0.8]
operatingProfitMarginTTM-0.001151.000-2.02-2.02[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2241.0009.879.87[0.2 - 2]
assetTurnoverTTM2.330.80010.008.00[0.5 - 2]
Total Score6.47

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-62.281.000-6.390[1 - 100]
returnOnEquityTTM-0.006172.50-0.758-1.769[0.1 - 1.5]
freeCashFlowPerShareTTM0.003102.0010.0010.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.01522.009.9910.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-53.941.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.007291.000-2.320[0.1 - 0.5]
Total Score-0.0605

Integrated BioPharma, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Integrated BioPharma,

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5571720600128 seconds
Number of API calls: 3
Number of DB calls: 9